Acessibilidade / Reportar erro

Hypertrophic scar mimicking peristomal pyoderma gangrenosum* Study conducted at the Department of Dermatology, Fukushima Medical University, Hikarigaoka, Fukushima, Japan.

Dear Editor,

Peristomal Pyoderma Gangrenosum (PPG) is a subtype of pyoderma gangrenosum, arising around the stoma after surgical placement of an ileostomy or colostomy in patients with inflammatory bowel diseases.11 Afifi L, Sanchez IM, Wallace MM, Braswell SF, Ortega-Loayza AG, Shinkai K. Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol. 2018;78:1195-1204.e1. Because there are a number of skin disorders involving the peristomal or parastomal areas, PPG may be overdiagnosed.22 Le ST, Wang JZ, Alexanian C, Ellis S, Martinez-Alvarado YC, Johng S, et al. Peristomal pyoderma gangrenosum: an exceedingly rare and overdiagnosed entity? J Am Acad Dermatol. 2019;81:e15. We herein describe an unusual case presenting with hyperkeratotic lesions around the stoma in a patient after colorectal cancer surgery.

A 78-year-old male after colorectal cancer surgery was referred to us, complaining of hypertrophic lesions surrounding the stoma. He received a colostomy 6-months previously, and peristomal skin lesions gradually worsened in these 2-months. He suffered from exudate from the lesions and pain associated with skin infections. Physical examination showed relatively well-circumscribed vegetating and keratotic lesions around the lower left abdominal stoma (Fig. 1). No abnormalities were found in the blood test.

Figure 1
Hyperkeratotic lesions presenting with well-circumscribed vegetating and keratotic appearances surrounding the stoma.

Histological features showed irregular hypertrophy of the epidermis, with dilated blood vessels in the papillary dermis and edematous upper dermis (Fig. 2A). Neutrophil infiltration and histological malignancy were not observed. Immunohistochemistry showed dense staining for vimentin in the mesenchymal cells in the dermis (Fig. 2B). CD31 staining showed a number of vessels, and CD31-positive vascular endothelial cells were observed throughout the dermis (Fig. 2C). α-Smooth Muscle Actin (SMA)-positive myofibroblasts were proliferated (Fig. 3A), which were partially positive for p16 (Fig. 3B). A diagnosis of hypertrophic scar was made, and the patient received reoperation of the stoma including the surrounding skin lesions.

Figure 2
(A) Histopathological features showing fibrosis of the thickened dermis. (B) Immunohistochemical examination using anti-vimentin antibody showed proliferation of mesenchymal cells. (C) The vessels in the dermis were increased in number, which were positive for CD31.

Figure 3
Myofibroblasts were increased in number, which were positively stained with α-SMA (A), and partially positive for p16 (B).

Peristomal pyoderma gangrenosum is a subtype of pyoderma gangrenosum, arising around the stoma in patients with inflammatory bowel diseases, and is observed in around 1% of patients with stoma.11 Afifi L, Sanchez IM, Wallace MM, Braswell SF, Ortega-Loayza AG, Shinkai K. Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol. 2018;78:1195-1204.e1. By contrast, it is also suggested that PPG is overdiagnosed from its clinical features.22 Le ST, Wang JZ, Alexanian C, Ellis S, Martinez-Alvarado YC, Johng S, et al. Peristomal pyoderma gangrenosum: an exceedingly rare and overdiagnosed entity? J Am Acad Dermatol. 2019;81:e15. Currently, there are no standard diagnostic criteria, and there are several conditions that should be differentiated from PPG. Those conditions include irritant and contact dermatitis, infection, overgranulation, pseudo verrucous lesion, and squamous cell carcinoma.33 Almutairi D, LeBlanc K, Alavi A. Peristomal skin complications: what dermatologists need to know. Int J Dermatol. 2018;57:257-264. In addition, other reports showed two cases of peristomal ulcerative conditions, which were eventually reclassified to be caused by irritant dermatitis;44 Barton VR, Le ST, Wang JZ, Toussi A, Sood A, Maverakis E. Peristomal ulcers misdiagnosed as pyoderma gangrenosum: a common error. J Eur Acad Dermatol Venereol. 2020;34:e108-e110. however, the hypertrophic scar was not included. The present case did not present with surrounding ulcers but hyperkeratotic lesions around the stoma. Histopathological examination did not reveal neutrophil infiltration in the dermis, but increased, thickened, and whorled collagen bundles, and a number of CD31-positive vessels throughout the dermis. Recent studies demonstrated strong expression of vimentin, α-SMA, and p16 in the hypertrophic/keloid scars, suggesting the proliferation of cellular senescence phase myofibroblasts.55 Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S. Hypertrophic and keloid scars fail to progress from the CD34-/α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression. Br J Dermatol. 2020;182:974-986. We should keep in mind that a number of inflammatory conditions assume clinical appearance mimicking PPG, and careful differentiation from other disorders is necessary for accurate diagnosis of PPG.

  • Financial support
    None declared.

References

  • 1
    Afifi L, Sanchez IM, Wallace MM, Braswell SF, Ortega-Loayza AG, Shinkai K. Diagnosis and management of peristomal pyoderma gangrenosum: a systematic review. J Am Acad Dermatol. 2018;78:1195-1204.e1.
  • 2
    Le ST, Wang JZ, Alexanian C, Ellis S, Martinez-Alvarado YC, Johng S, et al. Peristomal pyoderma gangrenosum: an exceedingly rare and overdiagnosed entity? J Am Acad Dermatol. 2019;81:e15.
  • 3
    Almutairi D, LeBlanc K, Alavi A. Peristomal skin complications: what dermatologists need to know. Int J Dermatol. 2018;57:257-264.
  • 4
    Barton VR, Le ST, Wang JZ, Toussi A, Sood A, Maverakis E. Peristomal ulcers misdiagnosed as pyoderma gangrenosum: a common error. J Eur Acad Dermatol Venereol. 2020;34:e108-e110.
  • 5
    Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S. Hypertrophic and keloid scars fail to progress from the CD34-/α-smooth muscle actin (α-SMA)+ immature scar phenotype and show gradient differences in α-SMA and p16 expression. Br J Dermatol. 2020;182:974-986.

Publication Dates

  • Publication in this collection
    15 Apr 2024
  • Date of issue
    Mar-Apr 2024

History

  • Received
    10 Mar 2022
  • Accepted
    16 July 2022
  • Published
    14 Dec 2023
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br